John Dillon

Academic, Clinical Professor (Teaching and Research) of Hepatology and Gastroenterology

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Dillon is a Clinical Professor (Teaching and Research) of Hepatology and Gastroenterology at the University of Dundee, UK. His research focuses on hepatology, particularly in the areas of hepatitis C treatment, viral hepatitis elimination, and the diagnosis of liver diseases. His recent publications include studies on treatment outcomes for people who inject drugs, HCV screening strategies, and the prevalence of hepatitis C in sub-Saharan Africa.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (27)

Sofia Bartlett

Adjunct Professor

The University of British Columbia

CANADA

John Dillon

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey

Post‐treatment life‐trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis

Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology

A scoping review on HCV screening strategies

Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review

Autologous macrophage therapy for liver cirrhosis

Future destinations

Diagnostic definitions of overdose and (opioid-induced) respiratory depression relevant to remote monitoring via accelerometry

Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Prevalence, trends, and distribution of hepatitis C virus among the general population in sub‐Saharan Africa: A systematic review and meta‐analysis

A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality

Intelligent Liver Function Testing (iLFT)

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis

Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease

Optimal ALT threshold for the automated diagnosis of MASLD

iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment

#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?

Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Improved health‐related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable

A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland

Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison

Admission care bundles for decompensated cirrhosis are poorly utilised across the UK: results from a multi-centre retrospective study

Research Priorities for Precision Medicine in NAFLD

Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C

Systematic review

Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland

Collaborators (27)

Sofia Bartlett

Josephine Walker

Lynn Gerber

Rachael Barrett

Kushala Abeysekera

Andrew Radley

Sharon Hutchinson

Peter Donnan

Alan Yeung

Stephen D. Ryder

Norah Palmateer

Magdalena Harris

Alexander Doney

William Rosenberg

helen jarvis

Matthew Hickman

Getahun Molla Kassa

Ify Mordi

Paul Flowers

Andrew McAuley

Chris Byrne

Daniela De Angelis

Sundararajan Srinivasan

Sarah Bowers

Sarah Donaldson

Marcela Villota-Rivas

Devnandan Chatterjee

Make your next move.